Should I cryopreserve my tumor tissue or use FFPE
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
I notice your question about tumor tissue preservation, but I want to make sure I'm giving you the most relevant guidance for your specific situation.
Before I dive into the technical details, could you help me understand the context a bit better?
A few clarifying questions:
-
Who is asking you to decide this? Are you being asked by your healthcare team to choose a preservation method for research purposes, clinical trials, or tumor banking?
-
What's the intended use? Is this for:
- Future genetic/biomarker testing?
- Participation in a research study?
- Tumor banking for potential future treatment decisions?
- Liquid biopsy or other molecular analysis?
-
When is this decision needed? Is this happening at the time of your biopsy or surgery?
Why I'm asking: The choice between cryopreservation (freezing fresh tissue) and FFPE (formalin-fixed paraffin-embedded, the standard preservation method) depends heavily on what your doctors plan to do with the tissue. This isn't typically a patient choice—it's usually determined by your medical team based on the clinical and research needs.
General context: FFPE is the standard method used for routine pathology and diagnosis. Cryopreservation is typically reserved for specific research purposes or biobanking when fresh tissue analysis is needed.
What you should ask your healthcare team:
- "Why are you asking me to choose a preservation method?"
- "What testing or research will be done with my tissue?"
- "What does your lab recommend for my specific situation?"
- "Will this affect my diagnosis or treatment planning?"
Once I understand your situation better, I can provide more targeted educational information about these preservation methods and help you formulate questions for your care team.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...
TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...
TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya
It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...
TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2